Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
21,442,876
-
Share change
-
-241,011
-
Total reported value
-
$109,995,475
-
Put/Call ratio
-
109%
-
Price per share
-
$5.13
-
Number of holders
-
56
-
Value change
-
-$2,087,446
-
Number of buys
-
29
-
Number of sells
-
21
Institutional Holders of FOAMIX PHARMACEUTICALS LTD - SHS (FOMX) as of Q1 2018
As of 31 Mar 2018,
FOAMIX PHARMACEUTICALS LTD - SHS (FOMX) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,442,876 shares.
The largest 10 holders included
GREAT POINT PARTNERS LLC, BAKER BROS. ADVISORS LP, FRANKLIN RESOURCES INC, DSC Advisors, L.P., PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, AXA, Opaleye Management Inc., Tekla Capital Management LLC, and Vivo Capital, LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.